Muscle–Kidney Crosstalk in Chronic Kidney Disease: From Molecular Mechanisms to Clinical Translation
European Journal of Clinical Investigation · 2026-11 · 56 (11)
DOI: 10.1111/eci.70288 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 17.11.2026. Verfasst von Antônio Anderson Ramos de Oliveira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Muscle, Skeletal, Kidney. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) frequently coexists with muscle dysfunction and wasting. This narrative review examines muscle–kidney pathways, clinical phenotypes, and kidney function assessment in altered muscle states.
Methods
We narratively synthesized experimental and clinical literature on inflammatory, oxidative, endocrine, metabolic, epigenetic, and functional pathways, classifying representative evidence by study design and translational limitations.
Results
Kidney‐to‐muscle mechanisms have broader experimental support than muscle‐to‐kidney pathways. Inflammation, mitochondrial injury, anabolic resistance, acidosis, uremic toxins, and endoplasmic reticulum stress promote wasting. Experimental studies implicate activin A signalling and nucleolar protein 66. Irisin and microRNA‐containing vesicles are candidate muscle‐to‐kidney mediators with limited human causal evidence. Prognostic associations are clearest for mortality; renal findings depend on phenotype, filtration estimates, and outcome ascertainment. Muscle composition and serial assessment provide complementary information. The creatinine‐to‐cystatin C ratio requires caution in advanced CKD and dialysis.
Conclusions
The muscle‐kidney axis integrates mechanistic and clinical observations. Experimental pathway manipulation and prognostic associations should be distinguished from therapeutic benefit in humans. Trials combining functional, molecular, and kidney outcomes are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.
ORCID-Profile: Antônio Anderson Ramos de Oliveira, Matheus Marques Mesquita da Costa, Maria Clara Pereira de Almeida, Danielle Pessoa Lima, Miguel Ângelo Nobre E Souza, Jarbas de Sá Roriz Filho, Elizabeth De Francesco Daher
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Anderson Ramos de Oliveira, A., Marques Mesquita da Costa, M., Escossio, A. L., Pereira de Almeida, M. C., Lima, D. P., Nobre E Souza, M. Â., de Sá Roriz Filho, J., & Daher, E. F. (2026). Muscle–Kidney Crosstalk in Chronic Kidney Disease: From Molecular Mechanisms to Clinical Translation. European Journal of Clinical Investigation, 56(11). https://doi.org/10.1111/eci.70288
Vancouver
Anderson Ramos de Oliveira A, Marques Mesquita da Costa M, Escossio AL, Pereira de Almeida MC, Lima DP, Nobre E Souza MÂ, et al. Muscle–Kidney Crosstalk in Chronic Kidney Disease: From Molecular Mechanisms to Clinical Translation. European Journal of Clinical Investigation. 2026;56(11). doi:10.1111/eci.70288
BibTeX
@article{AndersonRamosdeOliveira2026,
author = {Anderson Ramos de Oliveira, Antônio and Marques Mesquita da Costa, Matheus and Escossio, Alisson Lustosa and Pereira de Almeida, Maria Clara and Lima, Danielle Pessoa and Nobre E Souza, Miguel Ângelo and de Sá Roriz Filho, Jarbas and Daher, Elizabeth De Francesco},
title = {Muscle–Kidney Crosstalk in Chronic Kidney Disease: From Molecular Mechanisms to Clinical Translation},
journal = {European Journal of Clinical Investigation},
year = {2026},
volume = {56},
number = {11},
doi = {10.1111/eci.70288}
}
EUVIMED